DCM
JBIO
Driehaus Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Buy |
+1,255,798
| New | +$12.5M | 0.1% | 232 |
|
|
2024
Q2 | – | Sell |
-794,992
| Closed | -$23.5M | – | 370 |
|
|
2024
Q1 | $23.5M | Sell |
794,992
-263,217
| -25% | -$7.78M | 0.23% | 124 |
|
|
2023
Q4 | $23.9M | Sell |
1,058,209
-129,409
| -11% | -$2.93M | 0.29% | 111 |
|
|
2023
Q3 | $16.1M | Sell |
1,187,618
-6,473
| -0.5% | -$87.8K | 0.21% | 156 |
|
|
2023
Q2 | $20.5M | Buy |
+1,194,091
| New | +$20.5M | 0.26% | 123 |
|
|
2022
Q4 | – | Sell |
-46,864
| Closed | -$777K | – | 351 |
|
|
2022
Q3 | $777K | Buy |
+46,864
| New | +$777K | 0.01% | 310 |
|